SCHEMBL6937307

SCHEMBL6937307

O=C(Cc1ccccc1)Oc1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.67
▸ UCHL1 P09936 1/20 0.54
▸ USP5 P45974 1/20 0.54
▸ USP4 Q13107 1/20 0.54
▸ SENP1 Q9P0U3 1/20 0.54
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ PAM P19021 1/20 0.50
▸ CYP19A1 P11511 1/20 0.49
▸ CES1 P23141 2/20 0.47
▸ CES2 O00748 1/20 0.47
▸ AKR1B1 P15121 1/20 0.47
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 1/20 0.44
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31225490 0.90 SMN1; SMN2 (0.55) SMN1; SMN2UCHL1USP5USP4SENP1
SCHEMBL26011690 0.88 SMN1; SMN2 (0.61) SMN1; SMN2UCHL1USP5USP4SENP1
SCHEMBL31226055 0.85 KMT2A (0.55) SMN1; SMN2SENP1ALDH1A1L3MBTL1KMT2A
SCHEMBL9059841 0.84 SMN1; SMN2 (0.47) SMN1; SMN2UCHL1USP5USP4SENP1
SCHEMBL31226071 0.84 SENP1 (0.61) SMN1; SMN2UCHL1USP5USP4SENP1
SCHEMBL31225718 0.83 SMN1; SMN2 (0.51) SMN1; SMN2MAPK1ALDH1A1POLB
SCHEMBL20869833 0.82 SMN1; SMN2 (0.48) SMN1; SMN2UCHL1USP5USP4SENP1
SCHEMBL22499185 0.82 TDP1 (0.58) SMN1; SMN2TSHRALDH1A1L3MBTL1KMT2A
SCHEMBL31225821 0.82 KMT2A (0.52) SMN1; SMN2SENP1TSHRALDH1A1L3MBTL1
SCHEMBL31225807 0.82 SMN1; SMN2 (0.50) SMN1; SMN2UCHL1USP5USP4SENP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003091210-A1 A NEW SYNTHESIS FOR THE PREPARATION OF PORPHOBILINOGEN AND THE COMPOUND AS SUCH AS STABILIZED SALT AND INTERMEDIATES THEREOF NEIER REINHARD (CH) 2003-11-06 — — WO claimed
EP-1357110-A1 Synthesis for the preparation of porphobilinogen, the compound as such as stabilized salt and intermediates thereof Neier, Reinhard (CH) 2003-10-29 — — EP claimed
CN-1282640-C N-arylphenylacetamide derivatives and medicinal compositions containing same DAINIPPON PHARMACEUTICAL CO (JP) 2006-11-01 — — CN disclosed
CN-1529692-A N-arylphenylacetamide derivatives and medicinal compositions containing same 大日本制药株式会社 2004-09-15 — — CN disclosed
WO-2003091210-A1 A NEW SYNTHESIS FOR THE PREPARATION OF PORPHOBILINOGEN AND THE COMPOUND AS SUCH AS STABILIZED SALT AND INTERMEDIATES THEREOF NEIER REINHARD (CH) 2003-11-06 — — WO disclosed
EP-1357110-A1 Synthesis for the preparation of porphobilinogen, the compound as such as stabilized salt and intermediates thereof Neier, Reinhard (CH) 2003-10-29 — — EP disclosed
CN-1391473-A VLA-4 inhibitor compounds DAIICHI SEIYAKU CO (JP) 2003-01-15 — — CN disclosed
Send feedback